Page last updated: 2024-08-23

pirfenidone and Carditis

pirfenidone has been researched along with Carditis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, J; Li, H; Wang, Y; Wu, Y; Zhao, S	1

Other Studies

1 other study(ies) available for pirfenidone and Carditis

Article	Year
Pirfenidone attenuates cardiac fibrosis in a mouse model of TAC-induced left ventricular remodeling by suppressing NLRP3 inflammasome formation. Cardiology, 2013, Volume: 126, Issue:1 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrier Proteins; Collagen; Constriction; Fibrosis; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Interleukin-1beta; Male; Mice; Mice, Inbred BALB C; Myocarditis; Myocardium; Myocytes, Cardiac; Myofibroblasts; NLR Family, Pyrin Domain-Containing 3 Protein; Pyridones; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Survival Rate; Transforming Growth Factor beta1; Ventricular Remodeling	2013

Article

Year

Pirfenidone attenuates cardiac fibrosis in a mouse model of TAC-induced left ventricular remodeling by suppressing NLRP3 inflammasome formation.

Cardiology, 2013, Volume: 126, Issue:1

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrier Proteins; Collagen; Constriction; Fibrosis; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Interleukin-1beta; Male; Mice; Mice, Inbred BALB C; Myocarditis; Myocardium; Myocytes, Cardiac; Myofibroblasts; NLR Family, Pyrin Domain-Containing 3 Protein; Pyridones; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Survival Rate; Transforming Growth Factor beta1; Ventricular Remodeling

2013